InsidersTradesSigma
Follow the 特宝生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 特宝生物 has recorded 5 reports. Market capitalisation: €23.7bn. The latest transaction was reported on 15 July 2024 (Sale). Among the most active insiders: 王君业. All data is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,632 of 28,752 companies
69.3
score / 100
Value46
Quality93
FCF yld2.0%
Earn yld4.3%
EV/EBITDA18.4x
ROE32%
Gross mgn93%
Net mgn28%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 July 2024
Declarations5 total
5 of 5 declarations
About 特宝生物
特宝生物 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of biopharmaceutical products.